BioCentury | Feb 18, 2021
Management Tracks

Day One names York COO, CFO; plus moves at Coherus, Antios, ArsenalBio, Affinia, Artelo and more

...Vali as director of drug development. Kirshenbaum will retain his position as professor of chemistry at New York University...
BioCentury | Jan 15, 2021
Product Development

Paige to accelerate development, adoption of digital cancer diagnostic with $100M series C

...speed and predictive power of AI algorithms in analyzing histology images for cancer diagnoses and prognoses include Owkin Inc., Google Inc. and New York University...
BioCentury | Jan 9, 2021
Translation in Brief

Fusing camelid antibodies to toxin derivatives to treat botulism; plus BioNTech applies platform to multiple sclerosis, a molecule that stops axon degeneration and more

...derivatives shortened the duration of muscle paralysis and increased survival in mice. Wake Forest and New York University...
...Sterile alpha and TIR motif containing 1 Danielle Golovin Revlimid, lenalidomide (cdc 501, CC-5013) Boston Children's Hospital Wake Forest University New York University Johannes...
BioCentury | Jan 8, 2021
Product Development

Caplan sees a host of bioethical turning points coming out of the pandemic

...of the division of medical ethics at New York University...
BioCentury | Nov 6, 2020
Targets & Mechanisms

Data Byte: newly identified host factors that regulate ACE2 expression

...the ACE2 transcription start site and reduced ACE2 mRNA transcripts.Researchers from New York University...
...homolog WASHC3 (CCDC53) – WASH complex subunit 3 Danielle Golovin New York University Icahn...
BioCentury | Oct 31, 2020
Regulation

Expanding access to COVID-19 vaccines

...of the Division of Medical Ethics at New York University...
BioCentury | Oct 21, 2020
Product Development

How COVID-19 challenge trials will be shaped by emerging data

...quickly by permitting them than not,” Arthur Caplan, head of the Division of Medical Ethics at New York University...
BioCentury | Aug 20, 2020
Politics, Policy & Law

Recommendations to block fetal tissue funding break precedent by going over NIH’s head

...is in who has decision-making power. Caplan is head of the Division of Medical Ethics at New York University...
BioCentury | Jul 31, 2020
Product Development

U.K. locks down access to recombinant protein vaccine via GSK, Sanofi deal, its fourth for COVID-19

...start a Phase I trial by year-end. Repurposing Reata Reata Pharmaceuticals Inc. (NASDAQ:RETA) said the New York University...
BioCentury | Jul 3, 2020
Management Tracks

Angus Grant joins BeiGene; plus changes at Sarepta, RegenxBio, BioMarin, Novavax, Whitehead, Akcea and more

...Page as director of the Whitehead Institute for Biomedical Research. She joins the institute from New York University...
Items per page:
1 - 10 of 369
BioCentury | Feb 18, 2021
Management Tracks

Day One names York COO, CFO; plus moves at Coherus, Antios, ArsenalBio, Affinia, Artelo and more

...Vali as director of drug development. Kirshenbaum will retain his position as professor of chemistry at New York University...
BioCentury | Jan 15, 2021
Product Development

Paige to accelerate development, adoption of digital cancer diagnostic with $100M series C

...speed and predictive power of AI algorithms in analyzing histology images for cancer diagnoses and prognoses include Owkin Inc., Google Inc. and New York University...
BioCentury | Jan 9, 2021
Translation in Brief

Fusing camelid antibodies to toxin derivatives to treat botulism; plus BioNTech applies platform to multiple sclerosis, a molecule that stops axon degeneration and more

...derivatives shortened the duration of muscle paralysis and increased survival in mice. Wake Forest and New York University...
...Sterile alpha and TIR motif containing 1 Danielle Golovin Revlimid, lenalidomide (cdc 501, CC-5013) Boston Children's Hospital Wake Forest University New York University Johannes...
BioCentury | Jan 8, 2021
Product Development

Caplan sees a host of bioethical turning points coming out of the pandemic

...of the division of medical ethics at New York University...
BioCentury | Nov 6, 2020
Targets & Mechanisms

Data Byte: newly identified host factors that regulate ACE2 expression

...the ACE2 transcription start site and reduced ACE2 mRNA transcripts.Researchers from New York University...
...homolog WASHC3 (CCDC53) – WASH complex subunit 3 Danielle Golovin New York University Icahn...
BioCentury | Oct 31, 2020
Regulation

Expanding access to COVID-19 vaccines

...of the Division of Medical Ethics at New York University...
BioCentury | Oct 21, 2020
Product Development

How COVID-19 challenge trials will be shaped by emerging data

...quickly by permitting them than not,” Arthur Caplan, head of the Division of Medical Ethics at New York University...
BioCentury | Aug 20, 2020
Politics, Policy & Law

Recommendations to block fetal tissue funding break precedent by going over NIH’s head

...is in who has decision-making power. Caplan is head of the Division of Medical Ethics at New York University...
BioCentury | Jul 31, 2020
Product Development

U.K. locks down access to recombinant protein vaccine via GSK, Sanofi deal, its fourth for COVID-19

...start a Phase I trial by year-end. Repurposing Reata Reata Pharmaceuticals Inc. (NASDAQ:RETA) said the New York University...
BioCentury | Jul 3, 2020
Management Tracks

Angus Grant joins BeiGene; plus changes at Sarepta, RegenxBio, BioMarin, Novavax, Whitehead, Akcea and more

...Page as director of the Whitehead Institute for Biomedical Research. She joins the institute from New York University...
Items per page:
1 - 10 of 369